EBV BRLF1 134-142 (HLA-A*11:01)
( ATIGTAMYK )
HLA-A11 restricted epitope from Epstein-Barr Virus BRLF1 (134-142) is a linear peptidic epitope (epitope ID 5002) studied as part of Replication and transcription activator from Human herpesvirus 4 (Epstein Barr virus). This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assay
| Sequence: | ATIGTAMYK | |
| Gene: | BRLF1 | |
| Delivery: | 1-3 days | |
| C-Terminus: | OH | |
| N-Terminus: | H | |
| Amount: | 1 mg | |
| Counter Ion: | TFA | |
| Protein: | Replication and transcription activator | |
| UniProt Id: | P03209 | |
| Species: | Epstein-Barr virus (EBV; Human herpesvirus 4) | |
| Allele: | HLA-A*11:01 | |
| Application : | Cellular immune response, Immune monitoring, T-cell assays, Immunohistochemistry | |
| Indication : | Infectious disease, Cancer, Neuroscience | |
| Purity : | 95% HPLC-MS |
Protocols and Tips
Data sheets
Safety data sheet poly peptides:For your convenience, we have compiled a selection of publications
where our peptide products have been employed:
Publications >
€63.50*
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity: 95% HPLC-MS
More EBV BRLF1 peptides
